SLC1A5 and pancreatic adenocarcinoma: To provide a convenient and straightforward access to predict the 1-, 3-, and 5-year overall survival rates (OSR) of PAAD patients, we constructed a nomogram consisting of age, histopathological grade, TN stages, and SLC1A5 expression (Figure 4A).